These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 88951)

  • 1. A clinical study of low molecular weight-hydroxyethyl starch, a new plasma expander.
    Mishler JM; Parry ES; Sutherland BA; Bushrod JR
    Br J Clin Pharmacol; 1979 Jun; 7(6):619-22. PubMed ID: 88951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of hydroxyethyl starch in normal subjects.
    Yacobi A; Stoll RG; Sum CY; Lai CM; Gupta SD; Hulse JD
    J Clin Pharmacol; 1982 Apr; 22(4):206-12. PubMed ID: 6178760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hydroxyethyl starch and dextran on plasma volume and blood hemostasis and coagulation.
    Korttila K; Gröhn P; Gordin A; Sundberg S; Salo H; Nissinen E; Mattila MA
    J Clin Pharmacol; 1984 Jul; 24(7):273-82. PubMed ID: 6207208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation.
    Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
    Transfusion; 1996 May; 36(5):450-5. PubMed ID: 8693511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Second increase in plasma volume after single infusion of hydroxyethyl starch (author's transl)].
    Köhler H; Kirch W; Pitz H
    Klin Wochenschr; 1978 Oct; 56(19):977-83. PubMed ID: 81905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the molecular composition of circulating hydroxyethyl starch following consecutive daily infusions in man.
    Mishler JM; Ricketts CR; Parkhouse EJ
    Br J Clin Pharmacol; 1979 May; 7(5):505-9. PubMed ID: 89855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].
    Mishler JM
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):96-102. PubMed ID: 6159323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro comparison of the erythrocyte sedimenting properties of dextran, hydroxyethyl starch and a new low-molecular-weight hydroxyethyl starch.
    Strauss RG
    Vox Sang; 1979; 37(5):268-71. PubMed ID: 93347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion kinetics of hydroxyethyl starch 350/0.60 in normovolaemic man.
    Mishler JM; Ricketts CR; Parkhouse EJ
    J Clin Pathol; 1981 Apr; 34(4):361-5. PubMed ID: 6165740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macroamylasaemia following the infusion of low molecular weight-hydroxyethyl starch in man.
    Mishler JM; Dürr HK
    Eur Surg Res; 1979; 11(4):217-22. PubMed ID: 93539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donors.
    Strauss RG; Hester JP; Vogler WR; Higby DJ; Snikeris AC; Imig KM; Greazel C; Mallard G; Burnett D; Gupta S
    Transfusion; 1986; 26(3):258-64. PubMed ID: 2422795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of acetyl starch as a plasma volume expander in patients undergoing elective surgery.
    Behne M; Thomas H; Bremerich DH; Lischke V; Asskali F; Förster H
    Anesth Analg; 1998 Apr; 86(4):856-60. PubMed ID: 9539615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transfusion survival of hydroxyethyl starch 450/0.70 in man: a long-term study.
    Mishler JM; Ricketts CR; Parkhouse EJ
    J Clin Pathol; 1980 Feb; 33(2):155-9. PubMed ID: 6154064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasma kinetics of hydroxyethyl starch 350/0.60: a potential new adjunct for centrifugal leucapheresis.
    Mishler JM
    Am J Hematol; 1979; 7(4):341-7. PubMed ID: 94771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of postoperative prolonged plasma volume expansion with low molecular weight hydroxethy starch (HES 200/0.62, 6%).
    Degrémont AC; Ismaïl M; Arthaud M; Oulare B; Mundler O; Paris M; Baron JF
    Intensive Care Med; 1995 Jul; 21(7):577-83. PubMed ID: 7593900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological effects produced by the acute and chronic administration of hydroxyethyl starch.
    Mishler JM
    J Clin Apher; 1984; 2(1):52-62. PubMed ID: 6085628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of 6% hydroxyethyl starch 450/0.7, 10% dextran 40 and 3.5% gelatin on plasma volume in patients with terminal renal failure (author's transl)].
    Köhler H; Kirch W; Klein H; Distler A
    Anaesthesist; 1978 Sep; 27(9):421-6. PubMed ID: 82409
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of leucocyte-poor red blood cell suspensions prepared by sedimentation in hydroxyethyl starch.
    Dorner I; Moore JA; Collins JA; Sherman LA; Chaplin H
    Transfusion; 1975; 15(5):439-48. PubMed ID: 53916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume expansion of albumin, gelatin, hydroxyethyl starch, saline and erythrocytes after haemorrhage in the rat.
    Persson J; Grände PO
    Intensive Care Med; 2005 Feb; 31(2):296-301. PubMed ID: 15609019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion of hydroxyethylated amylopectin-protected frozen blood in man. I. Plasma clearance and renal excretion of the cryoprotectant.
    Mishler JM; Parry ES
    Vox Sang; 1979; 36(6):337-41. PubMed ID: 91262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.